Earnings calls

OneSource Speci. concall ledger

Every earnings call for ONESOURCE — management tone, guidance, KPIs and promise tracking, quarter by quarter.

ONESOURCE · 4 transcripts · Healthcare · latest Q3 FY26

Q3 FY26Published 24 Jan 2026Call held 24 Jan 2026

ONESOURCE Q3 FY26 Earnings Call Transcript & Analysis

Revenue2,903 million−26% YoYEBITDA173 millionAdjusted PAT-472 millionAdjusted EPS₹-4.1

Revenue 2903 million (−26% YoY); EBITDA 173 million; Adjusted PAT -472 million. Revenue reported at ₹2,903 million, representing a 26% YoY decline due to semaglutide approval delays in Canada.

Read full transcript & analysis

Q1 FY26Published 05 Aug 2025Call held 05 Aug 2025

ONESOURCE Q1 FY26 Earnings Call Transcript & Analysis

Revenue₹327.3 cr+12% YoYEBITDA₹88.5 cr+37% YoYEBITDA Margin27%Adjusted PAT₹37.1 crAdjusted EPS₹3.2

Revenue ₹327 cr (+12% YoY); EBITDA ₹88 cr (+37% YoY); EBITDA Margin 27%. Revenue reported at ₹327.3 crores, representing a 12% YoY growth.

Read full transcript & analysis

Q4 FY25Published 06 May 2025Call held 06 May 2025

ONESOURCE Q4 FY25 Earnings Call Transcript & Analysis

Revenue14,449 million+30% YoYOperating EBITDA4,665 million+100% YoYEBITDA Margin43%Adjusted PAT936 millionEPS₹21.4

Revenue 14449 million (+30% YoY); Operating EBITDA 4665 million (+100% YoY); EBITDA Margin 43%. Full year FY25 revenue exceeded ₹1,445 crores, representing 30% YoY growth.

Read full transcript & analysis

Q3 FY25Published 29 Jan 2025Call held 29 Jan 2025

ONESOURCE Q3 FY25 Earnings Call Transcript & Analysis

Revenue₹392.6 cr+18% YoYEBITDA₹143.2 crEBITDA Margin36%EPS₹7.8Net Debt₹581 cr

Revenue ₹393 cr (+18% YoY); EBITDA ₹143 cr; EBITDA Margin 36.0%. Revenue for Q3 FY25 stood at ₹392.6 crores, representing approximately 18% growth.

Read full transcript & analysis